Litigation Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (Fed. Cir. 2024)
✉ Email this page to a colleague
Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (Fed. Cir. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-08-29 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 10,213,400; 7,668,730; 7,765,106; 7,765,107; 7,895,059; 8,062,667; 8,202,537; 8,457,988; 8,589,182; 8,731,963; 8,772,306; 9,050,302; 9,486,426 | ||
| Link to Docket | External link to docket | ||
Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (Fed. Cir. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-09-30 | 29 | 19/02 69640 Al 9/2019 Megret et al. 10,213,400 B2 2/2019 Eller …States any patented invention during the term of the patent therefor, infringes the patent.” The… Roche patent. Id. Bolar wished to market a generic alternative to Dalmane once Roche’s patent expired…from using its patented compound “for any purpose whatsoever during the life of” its patent. Id. The district…economic impact on the patent owner’s exclusivity during the life of a patent.” H.R. Rep. No. 98-857, | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
